What are the specific side effects of Ripotinib?

As a multi-target tyrosine kinase inhibitor, Repotrectinib has shown significant efficacy in the treatment of ROS1-positive non-small cell lung cancer, but its use is also accompanied by a certain risk of side effects, and patients should be fully informed for early identification and management.

Clinical studies and real-world usage data show that common side effects of repotinib include gastrointestinal symptoms, such as nausea, vomiting, and diarrhea. This is a common reaction among a variety of targeted drugs and can usually be alleviated by adjusting the dosage time and symptomatic treatment. In addition, fatigue and weakness are also common, affecting patients' quality of life and requiring comprehensive care and rest adjustments.

In addition, repotinib may cause liver function abnormalities, such as elevated transaminases, so liver function indicators need to be monitored regularly during treatment. Some patients may also have hematological abnormalities, such as decreased white blood cell count, anemia, etc., and they need to pay close attention to changes in blood routine. Pulmonary adverse reactions such as interstitial lung disease (ILD) are rare but serious. If symptoms such as difficulty breathing and coughing occur, you should seek medical attention immediately.

Nervous system reactions such as headache and dizziness are occasionally seen, but are generally mild. Skin reactions such as rashes have also been reported. In general, most side effects can be alleviated after dose adjustment or symptomatic treatment under the guidance of a doctor, and adverse reactions rarely lead to drug discontinuation.

Because repotinib is a newer targeted drug, safety data is still accumulating. Patients should strictly abide by medical instructions, conduct regular physical examinations and follow-up, and detect side effects early and deal with them promptly to ensure the safety and effectiveness of treatment. Full management by a professional team is crucial to improving patient tolerance and quality of life.

In summary, although the efficacy of repotinib is outstanding, the side effects cannot be ignored. Scientific medication, standardized monitoring and timely intervention are the keys to ensuring patient benefit. Patients should work closely with doctors to jointly optimize treatment effects.

Reference materials:https://www.drugs.com/mtm/repotrectinib.html